688488 Jiangsu Aidea Pharmaceutical
- 7.17
- -1.29-15.25%
Jiangsu Aidea Pharmaceutical News
Eddy Pharmaceuticals Announcement on Participating in the 2024 Semi-Annual Science and Technology Innovation Board Special Group Performance Briefing on Pharmaceuticals and Biological Products
Eddy Pharmaceutical\'s announcement on applying for bank credit lines
Eddy Pharmaceutical\'s announcement on the plan for the company\'s directors and senior management to reduce their shareholding through centralized bidding
Eddy Pharmaceuticals Investor Relations Activity Record Form (2024-003)
Eddy Pharmaceutical\'s progress announcement on major asset restructuring matters
Notice of Subscription Agreement and Related Party Transaction Signed by Jiangsu Aidea Pharmaceuticals with Specific Party Subject to Certain Conditions
Jiangsu Aidea Pharmaceutical's announcement regarding the issuance of A shares to specific objects does not have any investors who directly or indirectly participate in subscriptions through related parties providing financial assistance or compensation.
Jiangsu Aidea Pharmaceutical Board of Directors' 2nd Session, 25th Meeting Resolution Announcement
Jiangsu Aidea Pharmaceutical's announcement on the dilution of immediate return of A-shares issued to specific parties, measures taken to fill the gap, and commitments made by relevant parties.
Summary of Acquisition Report of Jiangsu Aidea Pharmaceutical Co., Ltd.
Jiangsu Aidea Pharmaceutical Co., Ltd. Previous Fund Usage Verification Report
Jiangsu Aidea Pharmaceutical's Second Session of the Second Board of Supervisors Resolution Announcement
Announcement of Jiangsu Aidea Pharmaceutical requesting the approval of shareholders' meeting to subscribe to the objects and exempt the persons acting in concert from increasing the company's shares by means of a tender offer.
Announcement from Jiangsu Aidea Pharmaceutical regarding Mr. Fu Heliang's issuance of A-share stocks to specific individuals in the company for the year 2024
Jiangsu Aidea Pharmaceutical's plan to issue A-shares of stocks to specific entities in 2024.
Jiangsu Aidea Pharmaceutical's analysis report on the A-share stock issuance plan for specific recipients in 2024.
Jiangsu Aidea Pharmaceutical's explanation on the use of funds raised, which belongs to the field of technology innovation.
Jiangsu Aidea Pharmaceutical's shareholder dividend return plan for the next three years (2024-2026)
Jiangsu Aidea Pharmaceutical's feasibility analysis report on the use of funds raised through the issuance of A shares to specific objects in 2024.
Announcement about the disclosure of the A-share stock issuance plan by Jiangsu Aidea Pharmaceutical to specific parties
Analysis
Price Target
No Data
No Data